Clincosm LogoSign in Get a demo

Neoadjuvant Therapy

Showing 26 - 50 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma, Neoadjuvant Therapy, PD-1 Inhibitor Trial (PD-1 inhibitor+GP, GP)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • PD-1 inhibitor+GP
  • GP
  • (no location specified)
Jul 1, 2022

Non Small Cell Lung Cancer, Neoadjuvant Therapy, Immune Checkpoint Inhibitor Trial in Beijing (Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 17, 2022

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

Recruiting
  • Colorectal Cancer
  • +3 more
  • Neoadjuvant therapy with PD-L1 inhibitor
  • Guangzhou, Guangdong, China
    the Third Affiliated Hospital of Sun Yat-Sen University
May 10, 2022

Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard

Not yet recruiting
  • Neoadjuvant Therapy
  • standard long-term therapy
  • +5 more
  • (no location specified)
Apr 22, 2022

Breast Tumor, Neoadjuvant Therapy, Axillary Lymph Nodes Trial in Netherlands (RISAS)

Completed
  • Breast Neoplasm
  • +3 more
  • RISAS
  • Assen, Netherlands
  • +13 more
Feb 9, 2022

Gastric Cancer, Neoadjuvant Therapy Trial in Beijing (radiation, drug, procedure)

Recruiting
  • Gastric Cancer
  • Neoadjuvant Therapy
  • SIB-IMRT
  • +3 more
  • Beijing, China
    Department of Radiation Oncology, Cancer Hospital, Chinese Acade
Jan 20, 2022

Breast Cancer, HER2-low-expressing Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Guangzhou (Pyrotinib +

Recruiting
  • Breast Cancer
  • +3 more
  • Pyrotinib + epirubicin and cyclophosphamide followed by docetaxel treatment
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jan 11, 2022

Neoadjuvant Therapy Trial in Nanning (tislelizumab combined with axitinib)

Active, not recruiting
  • Neoadjuvant Therapy
  • tislelizumab combined with axitinib
  • Nanning, Jiangsu, China
    Hongqian Guo
Dec 13, 2021

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Lung Squamous Cell Carcinoma, Neoadjuvant Therapy, Immunotherapy Trial in Hangzhou (Tislelizumab)

Recruiting
  • Lung Squamous Cell Carcinoma
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of med
Aug 22, 2021

Breast Cancer, Rehabilitation, Neoadjuvant Therapy Trial in Toronto (Prehabilitation)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Prehabilitation
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Aug 3, 2021

Breast Cancer, Sentinel Lymph Node Biopsy, Neoadjuvant Therapy Trial in Tainan (SLNB + ALND)

Active, not recruiting
  • Breast Cancer
  • +2 more
  • SLNB + ALND
  • Tainan, Taiwan
    National Cheng Kung University Hospital
Jul 29, 2021

Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • PD-1 inhibitor+ Gemcitabine + Cisplatin
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Jun 23, 2021

Breast Tumors, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy Trial in Guangzhou (CEUS, blue dye)

Not yet recruiting
  • Breast Neoplasms
  • +2 more
  • CEUS
  • blue dye
  • Guangzhou, Guangdong, China
    The first affiliated hospital of Sun Yat-Sen university
Jun 18, 2021

Cervical Cancer, Chemo Effect, Programmed Cell Death 1 Receptor / Antagonists & Inhibitors Trial (Sindilimab +paclitaxel+

Not yet recruiting
  • Cervical Cancer
  • +3 more
  • Sindilimab +paclitaxel+ cisplantin
  • (no location specified)
Mar 14, 2021

Breast Cancer, Neoadjuvant Therapy, Lymph Node Metastases Trial in Netherlands

Recruiting
  • Breast Cancer
  • +2 more
    • 's Hertogenbosch, Netherlands
    • +26 more
    Mar 2, 2021

    Esophagus Cancer, Neoadjuvant Therapy Trial in Wuhan (Tislelizumab)

    Recruiting
    • Esophagus Cancer
    • Neoadjuvant Therapy
    • Wuhan, Hubei, China
      Union Hospital
    Feb 26, 2021

    Rectal Cancer, Neoadjuvant Therapy, Complete Remission Trial in Beijing (multi-points and full-thickness Biopsy, traditional

    Recruiting
    • Rectal Cancer
    • +3 more
    • multi-points and full-thickness Biopsy
    • traditional cCR
    • Beijing, Beijing, China
      Beijing Chaoyang Hospital
    Feb 4, 2021

    Surgery in Treatment of Locally Advanced Rectal Cancer (CRONOS)

    Active, not recruiting
    • Rectal Cancer
    • Neoadjuvant Therapy
    • Interval between NAT and surgery
    • Barcelona, Spain
      Hospital Clínic de Barcelona
    Feb 1, 2021

    Small-cell Lung Cancer, Neoadjuvant Therapy Trial in Shanghai (Atezolizumab, Carboplatin, Etoposide)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neoadjuvant Therapy
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jan 4, 2021

    Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

    Recruiting
    • Prostate Cancer
    • +3 more
    • Leuven, Vlaams-brabant, Belgium
      University Hospitals Leuven
    Dec 23, 2020

    Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Hangzhou (drug, procedure, other)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Neoadjuvant Therapy
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 10, 2020

    Neoadjuvant Therapy, Carilizumab, Apatinib Trial in Guangzhou (PD-1)

    Recruiting
    • Neoadjuvant Therapy
    • +3 more
    • PD-1
    • Guangzhou, Guangdong, China
      Cancer center of Sun Yat sen University
    Oct 9, 2020

    CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems

    Completed
    • Breast Cancer
    • +7 more
      • Beijing, Beijing, China
      • +11 more
      Sep 25, 2020

      Prehabilitation, Neoadjuvant Therapy, Liver Metastases Trial in Tarragona (Physical Prehabilitation)

      Not yet recruiting
      • Prehabilitation
      • +2 more
      • Physical Prehabilitation
      • Tarragona, Spain
        Hospital Universitari de Tarragona Joan XXIII
      Aug 18, 2020